• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “celmatix” Archives

          in
          Entry Author Date Location
          Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More Frank Vinluan 12/13/19 National
          “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum Ben Fidler 06/07/17 New York
          At the Alexandria Center Tomorrow: Can NY Biotech Seize the Moment? Ben Fidler 05/30/17 New York
          Last Chance to Save on “New York Biotech Seizes the Momentum” Jamie Gulden 05/25/17 New York
          Hurry & Save 20 Percent on New York Biotech Seizes the Momentum Jamie Gulden 05/17/17 New York
          Talk NY Bio With Schadt, Varmus & More on May 31: Discount Ends Today Jamie Gulden 04/11/17 New York
          Join Varmus, Foley & More at NY Biotech Seizes the Momentum on May 31 Ben Fidler 03/21/17 New York
          Celmatix Lands $4,799,999 New Round VentureDeal 04/04/16 New York
          Celmatix Secures $3,757,754 New Funding Round VentureDeal 09/15/15 New York
          Celmatix Obtains $5,510,000 New Funding Round VentureDeal 07/17/15 New York
          Celmatix Receives $4,012,850 New Funding VentureDeal 02/22/13 New York
          Celmatix Lands $1,499,997 New Financing VentureDeal 03/02/12 New York
          Celmatix Obtains Series A Funding VentureDeal 02/27/11 New York
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • How Healthy Are Your Market Access Programs?

            Sponsored · Whitepaper

            How Healthy Are Your Market Access Programs?

            A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs

            Archbow Consulting
          • Bridging the Diversity Gap with Decentralized Trials

            Sponsored · Whitepaper

            Bridging the Diversity Gap with Decentralized Trials

            How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender

            PRA Health Sciences
          • Xcelerating Life Sciences San Francisco: The Highlights Podcast

            From Our Editors · Podcast

            Xcelerating Life Sciences San Francisco: The Highlights Podcast

            The AI, Big Data, and R&D Boom

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.